<DOC>
	<DOCNO>NCT02003261</DOCNO>
	<brief_summary>This study examine superiority combine treatment transdiagnostic cognitive-behavior therapy ( Unified Protocol ; UP ) Treatment-As-Usual comparison waiting-list Treatment-As-Usual reduction depressive anxiety symptom among depressive anxiety disorder .</brief_summary>
	<brief_title>Japan Unified Protocol Clinical Trial Depressive Anxiety Disorders ( JUNP Study )</brief_title>
	<detailed_description>Participants depressive anxiety disorder randomize either Unified Protocol Treatment-As-Usual Wail-list Treatment-As-Usual . Intervention period 20-week follow-up period 43 week registration .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>DSMIV diagnosis Major Depressive Disorder , Dysthymia , Depressive Disorder Not Otherwise Specified , Panic Disorder With Agoraphobia , Panic Disorder Without Agoraphobia , Agoraphobia Without History Panic Disorder , Social Phobia ( Social Anxiety Disorder ) , ObsessiveCompulsive Disorder , Posttraumatic Stress Disorder , Generalized Anxiety Disorder , Anxiety Disorder Not Otherwise Specified assess SCID . Depressive anxiety symptom mild severe ( GRIDHAMD &gt; = 8 ) . Ages 20 year old , 65 year young screen . Subjects give full consent participation study . No alcohol substance use disorder 6 month prior screen assess SCID No current manic episode current schizophrenia psychotic disorder baseline assess SCID No serious suicidal ideation baseline ( GRIDHAMD Item3 severity 3 high . ) No lifethreatening , severe unstable physical disorder major cognitive deficit baseline . Evidence unable participate half intervention phase . No structured psychotherapy baseline . Other relevant reason decide investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>